Cannabinoid-1 Receptors in the Mouse Ventral Pallidum Are Targeted to Axonal Profiles Expressing Functionally Opposed Opioid Peptides and Contacting N-acylphosphatidylethanolamine-hydrolyzing Phospholipase D Terminals

Overview

Journal Neuroscience

Specialty Neurology

Date 2012 Aug 7

PMID 22863674

Citations 11

Authors

V M Pickel

E T Shobin

D A Lane

K Mackie

Affiliations

Soon will be listed here.

Abstract

The ventral pallidum (VP) is a major recipient of inhibitory projections from nucleus accumbens (Acb) neurons that differentially express the reward (enkephalin) and aversion (dynorphin)-associated opioid peptides. The cannabinoid-1 receptor (CB1R) is present in Acb neurons expressing each of these peptides, but its location in the VP is not known. To address this question, we used electron microscopic dual immunolabeling of the CB1R and either dynorphin 1-8 (Dyn) or Met(5)-enkephalin (ME) in the VP of C57BL/6J mice, a species in which CB1R gene deletion produces a reward deficit. We also used similar methods to determine the relationship between the CB1R and N-acylphosphatidylethanolamine (NAPE)-hydrolyzing phospholipase D (NAPE-PLD), an anandamide-synthesizing enzyme located presynaptically in other limbic brain regions. CB1R-immunogold was principally localized to cytoplasmic endomembranes and synaptic or extrasynaptic plasma membranes of axonal profiles, but was also affiliated with postsynaptic membrane specializations in dendrites. The axonal profiles included many single CB1R-labeled axon terminals as well as terminals containing CB1R-immunogold and either Dyn or ME immunoreactivity. Dually labeled terminals comprised 26% of all Dyn- and 17% of all ME-labeled axon terminals. Both single- and dual-labeled terminals formed mainly inhibitory-type synapses, but almost 16% of these terminals formed excitatory synapses. Approximately 60% of the CB1R-labeled axonal profiles opposed or converged with axon terminals containing NAPE-PLD immunoreactivity. We conclude that CB1Rs in the mouse VP have subcellular distributions consistent with on demand activation by endocannabinoids that can regulate the release of functionally opposed opioid peptides and also modulate inhibitory and excitatory transmission.

Citing Articles

Laminar Distribution of Cannabinoid Receptor 1 in the Prefrontal Cortex of Nonhuman Primates.

Han Y, Dong Q, Peng J, Li B, Sun C, Ma C Mol Neurobiol. 2023; 61(7):1-12.

PMID: 38062346 DOI: 10.1007/s12035-023-03828-4.

Inhibiting Endocannabinoid Hydrolysis as Emerging Analgesic Strategy Targeting a Spectrum of Ion Channels Implicated in Migraine Pain.

Della Pietra A, Savinainen J, Giniatullin R Int J Mol Sci. 2022; 23(8).

PMID: 35457225 PMC: 9027089. DOI: 10.3390/ijms23084407.

Adolescent administration of Δ-THC decreases the expression and function of muscarinic-1 receptors in prelimbic prefrontal cortical neurons of adult male mice.

Garzon M, Wang G, Chan J, Bourie F, Mackie K, Pickel V IBRO Neurosci Rep. 2021; 11:144-155.

PMID: 34667972 PMC: 8506972. DOI: 10.1016/j.ibneur.2021.09.005.

Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood.

Perez-Valenzuela E, Andres Coke M, Grace A, Fuentealba Evans J Int J Neuropsychopharmacol. 2020; 23(9):626-637.

PMID: 32710782 PMC: 7710918. DOI: 10.1093/ijnp/pyaa053.

Expression and localization of CB1R, NAPE-PLD, and FAAH in the vervet monkey nucleus accumbens.

Kucera R, Bouskila J, Elkrief L, Fink-Jensen A, Palmour R, Bouchard J Sci Rep. 2018; 8(1):8689.

PMID: 29875385 PMC: 5989267. DOI: 10.1038/s41598-018-26826-2.

References

Ellgren M, Artmann A, Tkalych O, Gupta A, Hansen H, Hansen S . Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects. Eur Neuropsychopharmacol. 2008; 18(11):826-34. PMC: 2745315. DOI: 10.1016/j.euroneuro.2008.06.009. View

Haller J, Varga B, Ledent C, Freund T . CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol. 2004; 15(4):299-304. DOI: 10.1097/01.fbp.0000135704.56422.40. View

Parolaro D, Vigano D, Rubino T . Endocannabinoids and drug dependence. Curr Drug Targets CNS Neurol Disord. 2005; 4(6):643-55. DOI: 10.2174/156800705774933014. View

Kalivas P, Jackson D, Romanidies A, Wyndham L, Duffy P . Involvement of pallidothalamic circuitry in working memory. Neuroscience. 2001; 104(1):129-36. DOI: 10.1016/s0306-4522(01)00054-9. View

Hurd Y . Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience. 1996; 72(3):767-83. DOI: 10.1016/0306-4522(96)00002-4. View

Hrabovszky E, Wittmann G, Kallo I, Fuzesi T, Fekete C, Liposits Z . Distribution of type 1 cannabinoid receptor-expressing neurons in the septal-hypothalamic region of the mouse: colocalization with GABAergic and glutamatergic markers. J Comp Neurol. 2011; 520(5):1005-20. DOI: 10.1002/cne.22766. View

Mitrovic I, Napier T . Mu and kappa opioid agonists modulate ventral tegmental area input to the ventral pallidum. Eur J Neurosci. 2002; 15(2):257-68. DOI: 10.1046/j.0953-816x.2001.01860.x. View

Smith K, Berridge K, Aldridge J . Disentangling pleasure from incentive salience and learning signals in brain reward circuitry. Proc Natl Acad Sci U S A. 2011; 108(27):E255-64. PMC: 3131314. DOI: 10.1073/pnas.1101920108. View

Groenewegen H, Berendse H, Haber S . Organization of the output of the ventral striatopallidal system in the rat: ventral pallidal efferents. Neuroscience. 1993; 57(1):113-42. DOI: 10.1016/0306-4522(93)90115-v. View

10.

Zimmer A, Zimmer A, Hohmann A, Herkenham M, Bonner T . Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc Natl Acad Sci U S A. 1999; 96(10):5780-5. PMC: 21937. DOI: 10.1073/pnas.96.10.5780. View

11.

Nikoshkov A, Hurd Y, Yakovleva T, Bazov I, Marinova Z, Cebers G . Prodynorphin transcripts and proteins differentially expressed and regulated in the adult human brain. FASEB J. 2005; 19(11):1543-5. DOI: 10.1096/fj.05-3743fje. View

12.

Cossu G, Ledent C, Fattore L, Imperato A, Bohme G, Parmentier M . Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res. 2001; 118(1):61-5. DOI: 10.1016/s0166-4328(00)00311-9. View

13.

Hohmann A, Herkenham M . Localization of cannabinoid CB(1) receptor mRNA in neuronal subpopulations of rat striatum: a double-label in situ hybridization study. Synapse. 2000; 37(1):71-80. DOI: 10.1002/(SICI)1098-2396(200007)37:1<71::AID-SYN8>3.0.CO;2-K. View

14.

Irving A, Coutts A, Harvey J, Rae M, Mackie K, Bewick G . Functional expression of cell surface cannabinoid CB(1) receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons. Neuroscience. 2000; 98(2):253-62. DOI: 10.1016/s0306-4522(00)00120-2. View

15.

Hashimotodani Y, Ohno-Shosaku T, Kano M . Endocannabinoids and synaptic function in the CNS. Neuroscientist. 2007; 13(2):127-37. DOI: 10.1177/1073858406296716. View

16.

Kalivas P, Churchill L, Klitenick M . GABA and enkephalin projection from the nucleus accumbens and ventral pallidum to the ventral tegmental area. Neuroscience. 1993; 57(4):1047-60. DOI: 10.1016/0306-4522(93)90048-k. View

17.

Valverde O, Noble F, Beslot F, Dauge V, Fournie-Zaluski M, Roques B . Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect. Eur J Neurosci. 2001; 13(9):1816-24. DOI: 10.1046/j.0953-816x.2001.01558.x. View

18.

Zhou L, Furuta T, Kaneko T . Chemical organization of projection neurons in the rat accumbens nucleus and olfactory tubercle. Neuroscience. 2003; 120(3):783-98. DOI: 10.1016/s0306-4522(03)00326-9. View

19.

de Souza Silva M, Jezek K, WETH K, Muller H, Huston J, Brandao M . Facilitation of learning and modulation of frontal cortex acetylcholine by ventral pallidal injection of heparin glucosaminoglycan. Neuroscience. 2002; 113(3):529-35. DOI: 10.1016/s0306-4522(02)00184-7. View

20.

Hreib K, Rosene D, Moss M . Basal forebrain efferents to the medial dorsal thalamic nucleus in the rhesus monkey. J Comp Neurol. 1988; 277(3):365-90. DOI: 10.1002/cne.902770304. View